Ventas (VTR) announces $1.0 billion life science investment.
Ventas, Inc. (VTR) announced today that the Ventas Life Science and Healthcare Real Estate Fund, L.P. has acquired a $1 billion portfolio of life science properties in the South San Francisco submarket. The Fund is a perpetual life vehicle managed by Ventas with assets under management of $1.8 billion. The acquired properties consist of three buildings totaling 800,000 sf and are 96% leased with a remaining average lease term of over six years.
Ventas is a large-cap health care REIT with a diversified portfolio of 1,204 properties located in the United States, Canada, and the United Kingdom. VTR is a member of the S&P 500 and has a total market capitalization of approximately $27 billion.
Ventas is a large-cap health care REIT with a diversified portfolio of 1,204 properties located in the United States, Canada, and the United Kingdom. VTR is a member of the S&P 500 and has a total market capitalization of approximately $27 billion.
10/16/2020